11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Editorial: How to Review Papers for A Neurosurgical Journal

      editorial
      , M.D.
      Surgical Neurology International
      Scientific Scholar

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          EDITORIAL As Editor-in-Chief of Surgical Neurology International, I was recently asked to be part of a panel of Editors of Neurosurgical Journals at the 2019 Congress of Neurological Surgeons (11/22/19), to discuss how to be a reviewer. “Do You Need to Know How To Write to be A Reviewer?” My response would be, “It helps.” If you are asked to join an editorial board, and have not been the primary author on at least several peer reviewed papers, do yourself and the journal a favor, and decline the offer. What Papers Should I Agree to Review? When you have been the primary author on several peer reviewed papers and decide to accept the invitation to serve as a reviewer, it is important to review not only papers directly in your field, but also those on related topics. I believe it is not fair to decline the multitude of reviews needed to support most journals on topics that might not be your main interest. In short, you shouldn’t just “pick and choose,” unless you have a conflict of interest. Definitions of a Conflict of Interest Note, there are multiple definitions of a conflict of interest; (1) you have worked with the authors before, (2) you have a ”bias” for/against the subject/authors, (3) you have a financial conflict, or (4) you have industry ties that disqualify you from being a reviewer. Further, as a reviewer, you also need to make sure that articles are not inappropriately tied to industry. You have to determine: (1) was the article funded by industry, (2) are you being asked to review an article or is it a white paper or infomercial/commercial (e.g., not a scientific study), (3) were specific products/instruments discussed, and if so, you have to determine whether the authors/product have been fully vetted and or fully tested, and (4) finally, do the procedures/instrumentation pose a significant potential risk/threat to patient safety? Performing a Review Perform an Overview The first step in reviewing an article is to perform an overview. This is best gleaned by first reading the title and abstract, and re-reading the purpose and conclusion of that abstract. Next, reading the last sentence of the introduction, and the first and last sentences of the discussion should indicate to you whether there is a premise/hypothesis that is later answered whether directly or indirectly, by the study design. You will need to answer whether there is in fact, an article present. Next, look to the methods section to check it for validity. Determine if the study design is adequate, is the sample size large enough, are the statistics appropriate, and is the study safe, and ethical? Document that there was an IRB (Internal Review Board), and also answer whether the IRB participants did their job, providing adequate informed consent. Other major considerations include; were the operations/procedures warranted, or was there overdiagnosis of disease, overuse of medical devices, and, therefore, unnecessary surgery.[2] Analysis of Methods and Results Sections The methods section should directly contribute to the results. One of the most common errors is finding clinical methods data within the first one to two paragraphs of the results section. Rather, the results section should offer paragraphs headed by first sentences that summarize the results for each part of the study designed. In short, results should not include a myriad of disorganized data (repetition). Rather, the results should be presented in an organized fashion, short/succinct analyses of the data for each facet of the study. Further, where appropriate, accurate tables and figures can keep extraneous data out of the text, and contribute to a short, well-organized results section. Assessment of the Discussion: Is There a New Contribution to the Literature? The discussion and conclusion sections should enable you to determine whether the article makes a new contribution to the literature. These sections should also analyze the results utilizing those found in the preceding literature. Critical to discussion sections is the avoidance of long and rambling unfocused diatribes. Too often, this section reads like a chapter rather than a focused review of the appropriate and relevant papers. Less experienced or some writers have a tendency to include extraneous studies that detract from the main point of the article. Conclusion The conclusion should typically be just one or two short sentences, and should summarize the article’s main findings. Limitations Many articles have a short section on limitations. This should be brief. However, you as a reviewer, will want to ask yourself whether the limitations invalidate the article. It is important that this section be keep short, concise, and to the point. References The number and type of references cited should be appropriate to the type of article being written. As a reviewer ask yourself whether key references were missed? Remember, you can easily check PubMed. Also, however, make sure the authors have avoided irrelevant references. Red Flags for Reviewers What are the red flags for poorly written articles? First and foremost, inexperienced authors typically write overly extensive and verbose introductions and discussion sections. Other statements you as a reviewer should look out for include: “This is the first paper…” Invariably, this is not the case. Additionally, as a reviewer, be suspicious if the data are too good; this may indicate that the study, at best, was not adequately performed, or at worse, was invalid. Remember when Carraggee et al. in 2011 looked at the 13 Bone Morphogenetic Protein/INFUSE studies (Medtronic, Memphis TN, USA) sponsored by industry, none of the studies reported any complications.[1] When to Consult the Editor in Chief (Eic) There are certainly occasions when you need to talk to the editor in chief. There are several issues that may warrant consulting with the EIC: is the study unethical or unsafe, is it a commercial/infomercial, was it already published elsewhere, and was it previously submitted and rejected by your journal. Further, if you suspect plagiarism, your EIC should be kept informed. Conclusion Reviewing is a hard job, but the intellectual rewards are limitless. Reviewing keeps you in touch with new developments, it challenges you intellectually, and continues your education beyond residency/fellowship. Further, it allows interaction with new ideas and new and long standing colleagues.

          Related collections

          Most cited references2

          • Record: found
          • Abstract: not found
          • Article: not found

          A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            “Evidence of Overuse of Medical Services Around the World” By Brownlee et al., Lancet, 2017: Does This Apply to Transforaminal Lumbar Interbody Fusions (TLIF)?

            INTRODUCTION In 2017, Brownlee et al. published a paper in Lancet entitled: “Evidence for overuse of medical services around the world.” In this article they discussed the overdiagnosis of “disease,” the overuse of medical devices, and resultant unnecessary treatments being performed in medicine/surgery. Here we reviewed Brownlee’s key points, and offer direct parallels to the present overuse of transforaminal lumbar interbody fusion (TLIF) to treat degenerative lumbar disc disease and stenosis with/without degenerative spondylolisthesis. Over Diagnosis, Overuse, and Overmedicalization of Medical Devices/Services Overdiagnosis Brownlee described overdiagnosis as the “…diagnostic labeling of abnormalities or symptoms that are indolent, nonprogressive or regressive, and that if left untreated or treated later will not cause significant distress or shorten the person’s life.”[2] They further discussed overdiagnosis as including “…the provision of medical services that are more likely to cause harm than good...”[2] Overuse Brownlee et al. (2017) defined: “…overuse in the form of aggressive treatment of clinically insignificant findings.”[2] In the US, they estimated overuse occurs in 6-8% of all cases, while in Medicare patients, the frequency was 29%.[2] Ausman provided yet another definition of overuse (personal communication, James I. Ausman, M.D.): “Overuse is the use of a tool or management of a problem unnecessarily.” Through a personal communication, Dr. Koo Van OverBeeke made the following comments regarding the overuse of spine instrumentation. He stated “We all know this is a money driven overuse. In the Netherlands the use of spinal instrumentation is restricted by rules from the insurance companies. Patients are not allowed to pay more by themselves; we do not have private practices for these surgeries. In other countries, such rules are known. Spinal instrumentation is much more common. Is it really necessary? It is something that we always wanted to know, but we are afraid to ask.” He also stated: “Because of the enormous rise of medical costs in the Netherlands, the ministry of health asked for a survey in order to see what is useful in the daily practice of all doctors working in Dutch hospitals. The preliminary result was that 50% of medical care was not proven to be of any effect compared with no medical treatment. Of course, medical treatment should be tailored to any individual patient , which means that a medical treatment can be useful for one patient and not for the other”. Overmedicalization Overmedicalization, according to Brownlee et al. consisted of: “…disease or abnormality…leading to populations previously considered “normal” or health being labeled as diseased.”[2] For example, degenerative findings attributed to the normal aging process in the spine should not necessarily be considered “disease” warranting any intervention; e.g. epidural injections, and surgery. Promoting such treatment options in the absence of significant “pathology” would, therefore, fall under their definition of overmedicalization. Further, Brownlee et al. described providing such services as those “… that are unnecessary in any way and for any reason…” for which there was no “… evidence or consensus-based guidelines….”[2] Application of Browlnee et al. Overuse, Overdiagnosis, and Overmedicalization As It Could Be Applied to TLIF (Transforaminal Lumbar Interbody Fusion) Certainly, overuse, overdiagnosis, and overmedicalization would apply to many of the transforaminal lumbar interbody fusions (TLIF) vs. decompression alone performed to treat lumbar disc disease, stenosis, with/without degenerative spondylolisthesis (DS). In 2018, Epstein reviewed the outcomes/complications of performing laminectomy alone for patients with 2-3 level (58 patients; stenosis/disc disease) and 4-6 level lumbar disease (79-disc disease/ stenosis/26 DS).[4] Postoperatively, patients experienced: no new neurological deficits, no infections, no adjacent segment disease (ASD), no readmissions, 1 reoperation (seroma; in-house postoperative day 7), and 4 (2.9%) cerebrospinal fluid fistulas.[4] These results were better than those complications cited in the literature associated with TLIF/MI TLIF that ranged from 7.7% to 23.0%. For example, for TLIF/MI TLIF, the following complication rates were reported; wound infections (8.3% vs. 0% for laminectomies alone), durotomies (6.1% vs. 2.9%), permanent neurological deficits (9.7% vs. 0%), new sensory deficits (20.2% vs. 0%), and reoperation rates (1.6-6% vs. 0.7%). The following additional complications were unique to TLIF/MI TLIF; 2.3% instrumentation failure, 1.26-2.4% cage migration, 0.8% cage extrusions, and 1.6% misplaced screws (1.6%), for an additional total complication rate of 7.1% not observed for laminectomy alone. SPORT Trial Documented Efficacy of Laminectomy (With or Without Fusion) For Lumbar Degenerative Spondylolisthesis (DS) Abdu et al. in their 2018 randomized controlled Spine Patient Outcomes Research Trial (SPORT) evaluated the 8-year outcomes for patients from 13 centers treated for DS utilizing “decompressive laminectomy (with or without fusion) versus standard nonoperative care.”[1] They found that DS treated surgically resulted in better 8-year outcomes vs. those managed non surgically. However, outcomes for all fusion groups were comparable; laminectomy with non- instrumented PLF (posterolateral fusion), instrumented PLF, and 360 instrumented fusions (e.g. including TLIF).[1] Not only should spinal surgeons reassess whether they are overdiagnosing and overmedicalizing DS, but they should also recognize and reemphasize the efficacy of laminectomy without fusion to avoid overusing medical devices. Failure of Industry-Supported Studies to Report Complications of TLIF/MI TLIF In 2011, the Carraggee et al. article “A Critical Review of Recombinant Human Bone Morphogenetic Protein-2 Trials in Spinal Surgery” reviewed the results of 13 Medtronic- funded studies in which they found skewed results favoring the product rhBMP-2.[3] They noted: “In the original peer review, industry-sponsored publications describing the use of rhBMP-2 in spinal fusion, particularly TLIF, adverse events …were either not reported at all, or not reported to be associated with rhBMP-2 use.”[3] In the 13 industry-sponsored rhBMP-2 publications, analyzing 80 patients receiving rhBMP-2 (e.g. in prospective controlled studies) they found: “No rhBMP-2-associated adverse events (0%).” Furthermore, the study designs were found to be heavily biased in favor of surgical RhBMP-2 use. Reviewing “FDA documents and subsequent publications” they found “originally unpublished adverse events and internal inconsistencies.” The result was the discovery of a previously unreported 10%-50% incidence of adverse events when using rhBMP-2 use in spine fusion (i.e. especially TLIF/MI TLIF), while a 40% risk of complications (e.g. including life-threatening events) occurred in patients undergoing anterior cervical fusion with rhBMP-2. CONCLUSION As so aptly described by Brownlee et al. (2017), today’s practice of spine surgery, particularly as it concerns TLIF/ MI TLIF, is overshadowed by the overdiagnosis, overuse, and performance of unnecessary operations.[2]
              Bookmark

              Author and article information

              Contributors
              Journal
              Surg Neurol Int
              Surg Neurol Int
              Surgical Neurology International
              Scientific Scholar (USA )
              2229-5097
              2152-7806
              2019
              20 December 2019
              : 10
              : 252
              Affiliations
              [1]Professor of Clinical Neurosurgery, School of Medicine, State University of New York at Stony Brook, New York, and Chief of Neurosurgical Spine and Education, NYU Winthrop Hospital, NYU Winthrop NeuroScience/Neurosurgery, Mineola, New York 11501, United States.
              Author notes
              [* ] Corresponding author: Nancy E. Epstein, M.D., NYU Winthrop Hospital, NYU Winthrop NeuroScience/ Neurosurgery, 200 Old Country Rd. Suite 485, Mineola, NY 11501, United States. nancy.epsteinmd@ 123456gmail.com
              Article
              SNI-10-252
              10.25259/SNI_580_2019
              6935948
              31893153
              f811ebcf-c3f3-48ac-8bff-56bf616d8a58
              Copyright: © 2019 Surgical Neurology International

              This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

              History
              : 03 December 2019
              : 03 December 2019
              Categories
              Editorial

              Surgery
              Surgery

              Comments

              Comment on this article